/ Published in 2025, Publication

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.
Watson-Jones D, Changalucha J, Maxwell C, Whitworth H, Mutani P, Kemp TJ, Kamala B, Indangasi J, Constantine G, Hashim R, Mwanzalima D, Wiggins R, Mmbando D, Connor N, Pavon MA, Lowe B, Kapiga S, Mayaud P, de Sanjosé S, Dillner J, Hayes RJ, Lacey CJ, Pinto L, Baisley K.
Lancet Glob Health. 2025 Feb;13(2):e319-e328.
DOI: 10.1016/S2214-109X(24)00477-7.
PMID: 39890232;
PMCID: PMC11783036.

What you can read next

The validity of an area-based method to estimate the size of hard-to-reach populations using satellite images
Rapid increase in prevalence of male circumcision in rural Tanzania in the absence of a promotional campaign.
Epidemiology of alcohol use and alcohol use disorders among people living with HIV on antiretroviral therapy in Northwest Tanzania: implications for ART adherence and case management.